Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
Novartis
Novartis
Isala
University Hospital, Rouen
University of Florida
Aristotle University Of Thessaloniki
University Hospital, Strasbourg, France
University of Kentucky
Erasmus Medical Center
Radboud University Medical Center
Pfizer
Oregon Health and Science University
Moi University
Nova Scotia Health Authority
Altamash Institute of Dental Medicine
Hoffmann-La Roche
Samaritan Health Services
Hennepin Healthcare Research Institute
Hoffmann-La Roche
University of Copenhagen
Hoffmann-La Roche
Boston Children's Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Ottawa Hospital Research Institute
Jiangsu Famous Medical Technology Co., Ltd.
VIFORFRANCE
Shenzhen Fifth People's Hospital
Gangnam Severance Hospital
Inovio Pharmaceuticals
Novartis
Mundipharma Korea Ltd
Mallinckrodt
GlaxoSmithKline
Seoul National University Hospital
Hospital Sao Joao
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
SpectraScience
Rijnstate Hospital
Seoul National University Hospital
Cttq
Janssen-Cilag Ltd.,Thailand
University of Oklahoma
University Hospital, Clermont-Ferrand
Sanofi
ActiViews Ltd.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
ActiViews Ltd.
GlaxoSmithKline
Shenzhen SiBiono GeneTech Co.,Ltd
Shenzhen SiBiono GeneTech Co.,Ltd
Goethe University